Moreover, the WNT signaling pathway and particularly the metabolic reprogramming of fatty acid oxidation (FAO) in DCs increases IDO expression while suppresses IL-6 and IL-12 cytokines; thus, aiding the tolerization of DCs within the tumor microenvironment and further contributes to anti-PD-1 immunotherapy resistance [176]. This evidence concerns the gene IDO1 and neoplasm.